anonymous
Guest
anonymous
Guest
NEW YORK (Reuters) - The chief executive of Memorial Sloan Kettering Cancer Center, Craig Thompson, resigned from the boards of drugmaker Merck & Co Inc (MRK.N) and lab services firm Charles River Laboratories International Inc (CRL.N) on Tuesday, following media investigations about the U.S. center’s ties to the pharmaceutical industry.
https://www.reuters.com/article/us-...-board-after-disclosure-scandal-idUSKCN1MC2VJ
https://www.reuters.com/article/us-...-board-after-disclosure-scandal-idUSKCN1MC2VJ